Literature DB >> 12527334

Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7.

Peter Mackenzie1, Joanna M Little, Anna Radominska-Pandya.   

Abstract

Previous studies have shown that several endogenous compounds, such as bilirubin and certain bile acids, are glucosidated in human liver. In this work, we have identified human UDP-glucuronosyltransferase 2B7 (UGT2B7) as the isoform that catalyzes the glucosidation of hyodeoxycholic acid (HDCA). The glucosidation by UGT2B7 was specific for HDCA and was not observed with the other bile acids examined, lithocholic acid, chenodeoxycholic acid, and ursodeoxycholic acid. The kinetics of HDCA glucuronidation and glucosidation by UGT2B7 were characterized. The K(m) values for glucuronidation and glucosidation of HDCA were 11.6 and 17.9 microM, respectively, with V(max) values of 4.15 nmol/min/mg protein for glucuronidation and 3.28 nmol/min/mg for glucosidation. At a fixed concentration of HDCA, the apparent K(m) for UDP-glucuronic acid was 89 microM with a V(max) of 3.53 nmol/min/mg. The corresponding parameters for UDP-glucose were 442 microM and 1.98 nmol/min/mg, respectively. UGT2B7 catalyzed the addition of the glucose and glucuronic acid moieties to an hydroxyl group on HDCA and also possessed some capacity to use UDP-xylose as sugar donor. The two polymorphic variants of UGT2B7, UGT2B7(*)1 and UGT2B7(*)2 could both glucosidate HDCA. This is the first report that identifies UGT2B7 as the enzyme responsible for the glucosidation of the bile acid, HDCA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527334     DOI: 10.1016/s0006-2952(02)01522-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.

Authors:  Robyn Meech; Anne Rogers; Lizhe Zhuang; Benjamin C Lewis; John O Miners; Peter I Mackenzie
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes.

Authors:  J E Slovak; K Mealey; M H Court
Journal:  J Vet Pharmacol Ther       Date:  2016-06-15       Impact factor: 1.786

3.  Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.

Authors:  Peter I Mackenzie; Anne Rogers; Joanna Treloar; Bo R Jorgensen; John O Miners; Robyn Meech
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

4.  Local differentiation of sugar donor specificity of flavonoid glycosyltransferase in Lamiales.

Authors:  Akio Noguchi; Manabu Horikawa; Yuko Fukui; Masako Fukuchi-Mizutani; Asako Iuchi-Okada; Masaji Ishiguro; Yoshinobu Kiso; Toru Nakayama; Eiichiro Ono
Journal:  Plant Cell       Date:  2009-05-19       Impact factor: 11.277

5.  Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction.

Authors:  Michael H Court; Suwagmani Hazarika; Soundararajan Krishnaswamy; Moshe Finel; J Andrew Williams
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

6.  Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism.

Authors:  Ryan T Bushey; Douglas F Dluzen; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2012-10-18       Impact factor: 3.922

7.  Comprehensive variant screening of the UGT gene family.

Authors:  Jason Yongha Kim; Hyun Sub Cheong; Byung Lae Park; Lyoung Hyo Kim; Suhg Namgoong; Ji On Kim; Hae Deun Kim; Young Hoon Kim; Myeon Woo Chung; Soon Young Han; Hyoung Doo Shin
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

8.  Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a Saudi population.

Authors:  Khalid M Alkharfy; Basit L Jan; Sibtain Afzal; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Saleh Al-Muhsen; Rabih Halwani; Mohammad K Parvez; Mohammed S Al-Dosari
Journal:  Saudi Pharm J       Date:  2016-06-02       Impact factor: 4.330

9.  Demethylzeylasteral exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A6 and 2B7.

Authors:  Jin-Wen Zhao; Gui-Hua Wang; Min Chen; Lian-Hua Cheng; Xiao-Qi Ji
Journal:  Molecules       Date:  2012-08-08       Impact factor: 4.411

10.  Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).

Authors:  E Bothos; E Ntoumou; K Kelaidoni; D Roukas; N Drakoulis; M Papasavva; F A Karakostis; P Moulos; K Karakostis
Journal:  J Transl Med       Date:  2021-04-15       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.